Among the many vexing issues faced by companies that conduct clinical trials, at least two of them — the large number of participants needed for trials and participants’ fears they will be end up ...

This piece is part of the CSIS International Security Program’s Transition46 series on Defense360. The last remaining bilateral arms control treaty between the United States and Russia—the New ...

REBECCA HERSMAN: With that, it is my great pleasure to introduce to you Senator Deb Fischer. She’s the senior senator from Nebraska. She’s a member of the Senate Armed Services Committee and chairman ...

Editor’s note: This is part of an “experts comment” series on the expiration of New START. With New START set to expire this week, the world is entering the first period since the end of the Cold War ...